📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Pioneering Role of GATA2 in Androgen Receptor Variant Regulation Is Controlled by Bromodomain and Extraterminal Proteins in Castrate-Resistant Prostate Cancer. (2019)

First Author: Chaytor L

Attributed to: MICA: Characterisation of a novel bromodomain inhibitor AZD5153 in castrate resistant prostate cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1541-7786.mcr-18-1231

PubMed Identifier: 30833300

Publication URI: http://europepmc.org/abstract/MED/30833300

Type: Journal Article/Review

Volume: 17

Parent Publication: Molecular cancer research : MCR

Issue: 6

ISSN: 1541-7786